pharma
Byondis Appoints Timo van den Berg as Senior Director, Immuno-Oncology R&D
In his new role, Van den Berg will be instrumental in helping shape Byondis’ IO pipeline, which includes the anti-SIRPα monoclonal antibody BYON4228.
Knowledge, entrepreneurship and innovation come together at Novio Tech Campus in Nijmegen. From Philips semiconductor production site, to Health and High Tech hotspot of the Netherlands. Explore us.
Based in Health Valley, with High Tech running through our DNA. At Novio Tech Campus open innovation between researchers and entrepreneurs in Health and High Tech leads to growth, making the campus an innovative hotspot of products and services for a better, healthier world. From a preventive malaria-drug, to a new generation of chips. It’s happening at Novio Tech Campus.
Novio Tech Campus is growing! In less than seven years Novio Tech Campus has provided housing for over 75 companies, employing more than 3,400 people. We focus on Health and High Tech, and service companies directly related to these industries. Discover them here.
We care about your privacy: Read more
In his new role, Van den Berg will be instrumental in helping shape Byondis’ IO pipeline, which includes the anti-SIRPα monoclonal antibody BYON4228.
// Become part of our growing community in Health and High Tech
